Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: Possible model of parkinsonian tremor

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 1, 1996, Pages 179-183

  Salamone, John ^a   Baskin, Patricia ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Acetylcholine; Dopamine; Motor; Parkinsonism; Purposeless chewing; Striatum; Tremor; Vacuous chewing

Indexed keywords

APOMORPHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; RESERPINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; JAW MOVEMENT; MALE; MONOAMINE METABOLISM; NONHUMAN; OSCILLATION; PARKINSONISM; PRIORITY JOURNAL; RAT; TREMOR; VIDEOTAPE;

ANIMALIA; PARKINSONIA;

EID: 0029932120     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)00164-6     Document Type: Article

References (36)

1. Adams, R. D.; Victor, M. Tremors, myoclonus, spasms and tics. In: Principles of neurology. New York: McGraw-Hill; 1981:69-77.
2. Agid, Y.; Guyenet, P.; Glowinski, J.; Beaujouan, J. C.; Javoy, F. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons of the rat. Brain Res. 86:488-492; 1975.
3. Baskin, P.; Gianutsos, G.; Salamone, J. D. Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding. Pharmacol. Biochem. Behav. 49:437-442; 1994.
4. Baskin, P.; Salamone, J. D. Vacuous jaw movements in rats induced by acute reserpine administration: Interactions with different doses of apomorphine. Pharmacol. Biochem. Behav. 46: 793-797; 1993.
5. Cools, A. R.; Hendriks, G.; Korten, J. The acetylcholine-dopamine balance in the basal ganglia of Rhesus monkeys and its role in dynamic, dystonic, dyskinetic epileptoid activity. J. Nerv. Trans. 36:91-105; 1975.
6. De Boer, P.; Abercrombie, E. D.; Heeringa, M.; Westerink, B. H. C. Differential effect of systemic administration of systemic administration of bromocriptine and L-DOPA on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats. Brain Res. 608:198-203; 1993.
7. Di Chiara, G.; Porceddu, M. L.; Vargiu, L.; Argiolas, A.; Gessa, G. L. Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264:564-567; 1976.
8. Duvoisin, R. C. Cholinergic-anticholinergic antagonism in parkinsonism. Arch. Neurol. 17:124-136; 1967.
9. Ellison, G.; See, R. Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia. Psychopharmacology 98:564-566; 1989.
10. Findley, L. J.; Gresty, M. A. Tremor. Br. J. Hosp. Med. 26:16-32; 1981.
11. Gianutsos, G.; Moore, K. E. Differential behavioral and biochemical effects of four dopaminergic agonists. Psychopharmacology 68:139-146; 1980.
12. Glassman, R. B.; Glassman, H. N. Oral dyskinesia in brain-damaged rats withdrawn from neuroleptic: Implication for models of tardive dyskinesia. Psychopharmacology 69:19-25; 1980.
13. Gunne, L. M.; Andersson, U.; Bondesson, U.; Johansson, P. Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol. Biochem. Behav. 25:897-901; 1986.
14. Gunne, L. M.; Growden, J.; Glaeser, B. Oral dyskinesia in rats following brain lesions and neuroleptic administration. Psychopharmacology 77:134-139; 1982.
15. Hunker, C. J.; Abbs, J. H. Uniform frequency of parkinsonian resting tremor in the lips, jaw, tongue and index finger. Mov. Disord. 5:71-77; 1990.
16. Jicha, G.; Salamone, J. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: Possible relation to parkinsonian symptoms. J. Neurosci. 11: 3822-3829; 1991.
17. Johansson, P.; Casey, D. E.; Gunne, L. M. Dose-dependent increases in rat spontaneous chewing rates during long-term administration of haloperidol but not clozapine. Psychopharmacol. Bull. 22:1017-1019; 1986.
18. Kelley, A. E.; Bakshi, V. P.; Delfs, J. M.; Lang, C. G. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: Pharmacological and regional specificity. Psychopharmacology 99:542-549; 1989.
19. Kostrzewa, R. M.; Brus, R.; Perry, K. W.; Fuller, R. W. Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain Res. 76:87-93; 1993.
20. Marsden,C. D.; Tarsy, D. Baldessarini, R. J. Spontaneous and drug-induced movement disorders in psychotic patients. In: Bendon, D. F; Blumer, D., eds. Psychiatric aspects of neurological disease. New York: Grune and Stratten; 1975:219-266.
21. McEvoy, J. P. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J. Clin. Psychopharmacol. 3:288-301; 1983.
22. Neisewander, J. L.; Lucki, I.; McGonigle, P. Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment. Brain Res. 558:27-35; 1991.
23. Noring, U.; Povlesen, U. J.; Casey, D. E.;, Gerlach, J. Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonism. Psychopharmacology 84:569-571; 1984.
24. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Cholinergic modulation of perioral behavior induced by chronic neuroleptic administration to rats. Psychopharmacology 79:226-230; 1983.
25. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Pharmacological characterization of spontaneous or drug-induced purposeless chewing movements in rats. Psychopharmacology 85:71-79; 1985.
26. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88:403-419; 1986.
27. Salamone, J. D.; Johnson C. J.; McCullough, L. D.; Steinpreis, R. E. Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacology 102:529-534; 1990.
28. Salamone, J. D.; Lalies, M. D.; Channell, S. L.; Iversen, S. D. Behavioral and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology 88:467-471; 1986.
29. Steinpreis, R. E.; Baskin, P. P.; Salamone, J. D. Vacuous jaw movements induced by subchronic administration of haloperidol: Interactions with scopolamine. Psychopharmacology 111:99-105; 1993.
30. Steinpreis, R. E.; Salamone, J. D. The effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats. Pharmacol. Biochem. Behav. 46:405-409; 1993.
31. Stewart, B. R.; Jenner, P.; Marsden, C. D.; Pharmacological characterization of pilocarpine-induced chewing in the rat. Psychopharmacology 97:228-234; 1988.
32. Stewart, B. R.; Rose, S.; Jenner, P.; Marsden, C. D. Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT. Eur. J. Pharmacol. 142:173-176; 1987.
33. Stoessl, A. J.; Martin-Iversen, M. T.; Barth, T. M.; Dourish, C. T.; Iversen, S. D. Effects of ageing on the behavioural responses to dopaminergic agonists: Decreased yawning and locomotion, but increased stereotypy. Brain Res. 495:20-30; 1989.
34. Tarsy, D. Neuroleptic-induced extrapyramidal reactions: Classification, description and diagnosis. Clin. Neuropsychopharmacol. 6:S9-s26; 1983.
35. Tissarini, A. H.; Lillgals, M. S. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration. J. Neurochem. 61: 231-238; 1993.
36. Waddington, J. L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431-447; 1990.